STOCK TITAN

Sale of 30,743 ADS planned for NVS (NVS) under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of the issuer’s American Depositary Shares has filed a notice of planned resale under Rule 144. The filing covers 30,743 American Depositary Shares, with an aggregate market value of 4,960,276.69, to be sold through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of 02/12/2026. These shares were acquired on 01/29/2026 via restricted stock vesting as compensation from the issuer. The filing notes that shares of the same class outstanding total 1,908,151,679.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for NVS disclose?

The Form 144 discloses a planned resale of 30,743 American Depositary Shares on the NYSE under Rule 144, using Fidelity Brokerage Services LLC as broker, with an approximate sale date of 02/12/2026 and aggregate market value of 4,960,276.69.

How many NVS American Depositary Shares are planned for sale?

The notice covers a planned sale of 30,743 American Depositary Shares. These securities were acquired on 01/29/2026 through restricted stock vesting from the issuer as compensation and are to be sold on the NYSE through Fidelity Brokerage Services LLC.

What is the aggregate market value of the NVS shares to be sold?

The planned Rule 144 sale has an aggregate market value of 4,960,276.69. This figure reflects the total market value of the 30,743 American Depositary Shares that the holder intends to sell on the NYSE through Fidelity Brokerage Services LLC.

When were the NVS shares acquired and how?

The 30,743 American Depositary Shares were acquired on 01/29/2026 via restricted stock vesting. The filing states the shares were obtained from the issuer as compensation, and they are now the subject of a planned resale under Rule 144.

What is the approximate sale date for the NVS shares in the Form 144?

The planned sale date in the notice is approximately 02/12/2026. On or around this date, the holder intends to sell 30,743 American Depositary Shares on the NYSE, with an aggregate market value reported as 4,960,276.69.

How many NVS shares of the same class are outstanding?

The filing reports that 1,908,151,679 shares of the same class are outstanding. This number provides context for the planned resale of 30,743 American Depositary Shares under Rule 144 by the filing holder through Fidelity Brokerage Services LLC.
Novartis

NYSE:NVS

NVS Rankings

NVS Latest News

NVS Latest SEC Filings

NVS Stock Data

311.22B
1.91B
Drug Manufacturers - General
Healthcare
Link
Switzerland
Basel